Skip to content
Lower risk Drug recall · FDA · Published March 25, 2014

Hospira Demerol ampoules missing label - recall for safety

Hospira recalls Demerol 25 mg/0.5mL ampoules (NDC 0409-1203-01) due to missing container labels. This labeling issue could lead to incorrect use. Consumers should check their product and contact Hospira for details.

🇺🇸 FDA recall #D-1226-2014DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer

Hospira is recalling Demerol injection ampoules that lack the required container label. This missing label could lead to incorrect use or dosing errors, especially since the product is prescription-only. Read more at govinfonow.com/recall/46174-hospira-demerol-ampoules-missing-label-recall-for-safety.

Source Summary by GovInfoNow · govinfonow.com/recall/46174-hospira-demerol-ampoules-missing-label-recall-for-safety · Updated August 20, 2026 · FDA enforcement record: FDA #D-1226-2014

Cite this page

“Hospira Demerol ampoules missing label - recall for safety.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/46174-hospira-demerol-ampoules-missing-label-recall-for-safety. Based on FDA recall #D-1226-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1226-2014%22&limit=1).

The FDA announced on March 25, 2014, that Hospira Inc. voluntarily recalled Demerol meperidine HCL Inj. USP ampoules due to missing immediate container labels. The recall affects 237,850 units distributed nationwide.

How to tell if you have it

  • Brand: Hospira
  • Product: Demerol, meperidine HCL Inj. USP, 25 mg/0.5 mL (50 mg/mL), 0.5 mL ampoules
  • NDC: 0409-1203-01
  • Lot: 221303A
  • Expiration date: 1OCT2014

The hazard

The ampoules are missing the immediate container label, which constitutes a labeling hazard. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show Hospira Inc. has issued 108 other recalls since April 5, 2012. Other recent recalls of similar products include American Regent Levocarnitine Injection Recall (April 16, 2026) and Nephron Albuterol Inhaler (March 17, 2026).

How to tell if you have this one

Check for Demerol 25 mg/0.5 mL (50 mg/mL) ampoules with NDC 0409-1203-01. The product was sold with lot number 221303A, manufactured in October 2014.

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the missing container label on the Demerol ampoules. If the label is missing, stop using the product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 21 months after the firm started it.

1. Firm started the recall: Mar 25, 201412. FDA classified it Class III: Apr 8, 201423. Published in FDA’s Enforcement Report: Apr 16, 201434. FDA terminated the recall: Dec 18, 2015420142015
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1226-2014 (March 25, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1226-2014 to see it in context.
  • Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA